CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
about
Association between NQO1 C609T polymorphism and prostate cancer riskEffects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han ChineseAssociation between IL-4 -590C>T polymorphism and gastric cancer risk.Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma.Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs.Hormone-related pathways and risk of breast cancer subtypes in African American women.SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.The prognostic value of elevated ezrin in patients with osteosarcoma.Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysis.Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility.Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility.Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.The prognostic value of Smad4 mRNA in patients with prostate cancer.Association between IL-4 -589C>T polymorphism and colorectal cancer risk.Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma.A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length.Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.Association between interleukin-4 -590C > T polymorphism and non-Hodgkin's lymphoma risk.Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis.Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysisInfluence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer
P2860
Q28240340-58FFEB9F-CB2B-4055-BED0-537D94F562B2Q34315186-32C371CD-2C10-4BB1-B208-8175DE2066CFQ35000510-6F85C538-98E9-4568-B8CD-BC5773B6F5E6Q35033273-43B47AF0-5641-433B-97AB-A027F748EFA9Q35056269-4A95C240-E412-4C09-B90A-56E0543FE7FAQ36264616-4EB4D42A-815F-47DA-B785-578F5F377EB2Q37371491-A773CBB5-AB21-4822-BD2D-C612FF1D73F4Q38129332-10724919-FB28-480D-9CBD-B414A889A1C2Q38135314-82887BE6-AC8E-4F74-8FC7-6204E569648CQ38160390-E2F3C599-9BFE-4A4D-926F-7452A7A8D2E3Q38169608-87FA5319-F3B5-4BF8-B9A8-BAF5495F28A8Q38181968-D1A6993F-4008-4AB8-A068-D6074A6694C2Q39368655-8D02A465-81B2-4EC9-AE4A-C7AF73776B89Q44635848-773C7806-62EA-4345-BF4C-D2C26F5C157CQ44984281-E7871148-8B76-44FD-8B76-B64D5E73A1F5Q46735674-7EC55A57-5A4D-4897-86D6-E087533BE03FQ46838376-C96888DD-4C3F-4CE3-AB0D-4140AB43E9F4Q49520171-B9F5DECF-7160-4561-B94F-13E47EC7C9B7Q51127565-34B8334F-B773-47C6-9C9F-70ACB6175EA5Q53134069-EC7DAC54-4A23-45E9-B5B6-EF48E22073F4Q53134756-83B5E309-826C-4BD9-B1E7-3E8072F93DC9Q53154506-8A60BFB3-3988-4988-93D4-37C58901FC4AQ54542309-575B382B-23A9-43F3-B634-097AC3553189Q54759427-6D9499F6-792D-4774-9A25-EF1CF6CBF5DBQ56515034-3AFD6F9D-16A0-408B-A415-48833996A24EQ57105341-F43BB86E-F23D-47F2-BDB9-508D01C84D24
P2860
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@ast
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@en
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@nl
type
label
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@ast
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@en
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@nl
prefLabel
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@ast
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@en
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@nl
P2093
P2860
P1433
P1476
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0068634
P407
P577
2013-07-04T00:00:00Z